Patriot Act Reauthorization: A Legal Analysis (CRS)
The existing controversy over reauthorization of the USA Patriot Act — portions of which will “sunset” if they are not renewed — acquired a new dimension with the disclosure last month of an NSA domestic surveillance operation.
Some now argue that the Patriot Act should not be reauthorized before the Bush Administration’s claims of inherent presidential authority to conduct domestic intelligence surveillance outside of the framework of law (FISA) are confronted and clarified.
“The extensive new powers requested by the executive branch in its proposal to extend and enlarge the Patriot Act should under no circumstances be granted unless and until there are adequate and enforceable safeguards to protect the Constitution and the rights of the American people against the kinds of abuses that have so recently been revealed,” said former Vice President Al Gore in a January 16, 2006 speech.
Much of the Patriot Act is unobjectionable to anyone, and some of it is positively sensible. But it also has controversial provisions on “national security letters” as well as several totally extraneous provisions inserted by House Republicans.
A detailed assessment of the entire piece of legislation was prepared by the Congressional Research Service. A copy was obtained by Secrecy News.
See “USA PATRIOT Improvement and Reauthorization Act of 2005 (H.R. 3199): A Legal Analysis of the Conference Bill,” January 17, 2006.
The transition to a clean energy future and diversified sources of energy requires a fundamental shift in how we produce and consume energy across all sectors of the U.S. economy.
A deeper understanding of methane could help scientists better address these impacts – including potentially through methane removal.
While it is reasonable for governments to keep the most sensitive aspects of nuclear policies secret, the rights of their citizens to have access to general knowledge about these issues is equally valid so they may know about the consequences to themselves and their country.
Advancing the U.S. leadership in emerging biotechnology is a strategic imperative, one that will shape regional development within the U.S., economic competitiveness abroad, and our national security for decades to come.